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The aim of this study was to evaluate the impact of vibroacoustic stimulation (VAS) on computerized cardiotocography short-
term variability (STV) and approximate entropy (ApEn) in both low- and high-risk pregnancies. VAS was performed on 121 high-
and 95 low-risk pregnancies after 10 minutes of continuous quiet, while their FHR parameters were monitored and recorded by
cCTG analysis. Fetal heart rate was recorded using a computer-assisted equipment. Baseline FHR, accelerations, decelerations,
STV, long-term irregularity (LTI), ApEn, and fetal movements (FMs) were calculated for deﬁned observational periods before VAS
and after 10 minutes. Data were also investigated in relationship with the perinatal outcome. In each group of patients, FHR after
VAS remained almost unmodiﬁed. Fetal movements signiﬁcantly increased after VAS in both groups. Results show that only in
the high-risk pregnancies, the increase of STV and the decrease of ApEn after VAS were signiﬁcantly associated with favorable
perinatal outcomes.
1.Introduction
Several studies [1–4] showed that fetal sleeping periods can
lead to falsely nonreactive tests, therefore, increasing the risk
of unnecessary obstetric intervention. Attempts to arouse
the fetus while is sleeping or in a rest-activity cycle include
a change in maternal position, physical activity, maternal
glucose ingestion, sound stimulation, light stimulation, and
manual fetal manipulation. However, the only stimuli that
have consistently evoked responses in normal fetuses are
acoustic and vibrotactile ones. Fetal vibroacoustic stimula-
tion was ﬁrst noted in 1947 by Bernard and Sontag [5]w h o
observed that the fetal heart rate accelerated after acoustic
stimulation [6] correlated fetal movements with fetal well-
being.
Inmodernobstetrics,fetalvibroacousticstimulationuses
an artiﬁcial larynx placed on the mother’s abdomen over
the fetal head region. This is expected to induce a startle
reﬂex in the fetus, with subsequent fetal movement and FHR
acceleration [7]. Many authors have observed an increase in
the frequency and size of accelerations after vibroacoustic
stimulation during low FHR [8–10]. It is hypothesized that
FHR acceleration following VAS provides reassurance of
fetal well-being, obviating the need for further intervention
[11, 12]. Moreover, acoustic stimulation of the fetus has
been suggested to improve the eﬃciency of antepartum fetal
heart rate testing [13, 14]. Some authors in nonrandomized
studies [15–17] have reported success using fetal vibroa-
coustic stimulation to improve the eﬃciency of antepartum
fetal heart rate testing without changing the predictive
reliability of the tests. Animal studies have revealed that fetal
responses to extrauterine sound depend on the peripheral
and central components of the fetus’s auditory system. In
lambs with bilateral cochlear ablation, no reactions towards2 Journal of Pregnancy
Table 1: Patients’ characteristics.
Number %
Gestational age at CTG recording (week):
28–36 weeks
37–42 weeks
87
129
40.27
59.72
High-risk pregnancy 121 56
Low-risk pregnancy 95 44
Abnormal Doppler velocimetry on umbilical cord 10 4.63
Abnormal AFI, n (%):
<5cm 6 2.8
>25cm 4 1.8
CTG, cardiotocogram; AFI, amniotic ﬂux index.
vibroacoustic stimulation could be recorded, not even at
high intensities, indicating that the auditory apparatus is
necessary for fetal heart rate (FHR) and fetal movement
(FM) responses in this animal model [18, 19]. Some authors
have conducted studies to evaluate the existence of possible
adverse eﬀects caused by the VAS [20]. They concluded
that stimulation with the electronic artiﬁcial larynx induced
excessive fetal movements, a prolonged tachycardia, non-
physiologicalstatechanges,andadisorganisationandchange
in the distribution of fetal behavioural states, therefore, they
did not recommend its use routinely. On the other hand,
in more recent studies [21], vibroacoustic stimulation has
been demonstrated not to cause any cochlea damage in the
fetus, and they have shown that the intensity of sound and
vibration are 4000 times less than in the amniotic ﬂuid,
compared to that produced in air. Moreover, an audiometric
and tympanic screening performed on children who had
been exposed to vibroacoustic stimulation in utero showed
the absence of hearing loss [22].
Positive (reactive) VAS tests appeared comparable to
standard reactive nonstress tests (NSTs) [23]. Perinatal out-
comes following positive VAS appear to be similar to those
associated with reactive NSTs, while testing time was shorter
with VAS [24].
Since computerized cardiotocography (cCTG) provides
an objective analysis of FHR, our aim of this study was to
evaluate FHR before and after VAS, in both low- and high-
risk pregnancies. Moreover, the cCTG parameters short-
term variability (STV) and approximate entropy (ApEn) are
considered more closely related to the actual well-being of
the fetus, compared to the parameters detectable with the
traditional reading [25]. Therefore, in the present study, we
decided to consider especially them, in an attempt to provide
an even more reliable evidence of fetal well-being.
2.MaterialsandMethods
A retrospective study was performed in 563 pregnants
referring to the “Federico II” University Medical School in
Naples, between November 2007 and October 2010. The
studywasapprovedbyethicscommitteeoftheuniversityand
all participants gave their written informed consent.
Table 2: Babies’ characteristics.
Number %
SGA 17 7.8
Adverse perinatal
outcome 5minApgarscore<7 23 10.7
RDS 2 0.93
Perinatal death 2 0.93
NICU admission 6 2.8
Good perinatal outcome 166 76.85
SGA, small for gestational age; RDS, respiratory distress syndrome; NICU,
neonatal intensive care unit.
Patients were selected according to some inclusion
criteria: (a) availability of data from maternal medical his-
tory, ultrasound parameters, amniotic ﬂuid production,
Doppler velocimetry on umbilical cord; (b) computerized
cardiotocographic (cCTG) analysis from antepartum FHR
tracings before and after fetal vibroacoustic stimulation;
(c) availability of data about the newborn baby (kind of
delivery, sex, weight, Apgar score, malformations at birth,
and the possible need of admission in neonatal intensive
care). Moreover, each FHR tracing had to contain (a) a
period of 10 minutes of continuous quiet before the stimulus
was given and (b) a period of at least 10 minutes after the
stimulus was given, both of acceptable quality, according
to the analysis criteria [26]. Exclusion criteria for ﬁnal
analysis were (a) FHR tracings before the twenty-eighth
week of pregnancy, for which the International Federation
of Gynecology and Obstetrics does not provide any standard
value for the cCTG parameters; (b) patient withdrawal
from the study and/or unavailability of followup. Total
population included 216 patients, divided in two groups:
low- and high-risk pregnancies. “High-risk” pregnancy is
generally thought of as the one in which the mother or the
developing fetus has a condition that places one or both
of them at a higher-than-normal risk for complications,
either during the pregnancy (antepartum), during delivery
(intrapartum), or following the birth (postpartum). Instead,
low-risk pregnancy is deﬁned for the absence of signiﬁcant
past medical or obstetric history and of fetal anomalies
[27, 28]. The characteristics of the population of this study
are shown in Tables 1 and 2. Pregnancy care was performed
according to routine practice. All patients underwent the
cCTG nonstress test in the same conditions, that is, in the
same rooms, between 8.30 and 12.00 AM and with the
women in semirecumbent position. Fetal heart rate was
recordedusing a computer-assisted equipment(Corometrics
170, General Electrics). Each FHR tracing was analyzed
with the SEA 2CTG2 system that calculated the short term
variability throughout this expression.
STV = mean[|T24(i+1 ) −T24(i)|]
=
23 
i=1
|T24(i+1 ) −T24(i)|
23
.
(1)
Approximate entropy (ApEn) derives from formulas sug-
gested to estimate the Kolmogorov entropy of a processJournal of Pregnancy 3
Table 3: FHR parameters before and after VAS in low-risk
pregnancies (n = 95).
Before VAS After VAS P∗
FHR 137.14 137.33 N.S.
FM 36 72 0.001
N◦ ACC 2.2 8.6 0.001
DEC 0.01 0.11 N.S.
STV 4.75 5.28 N.S.
ApEn 1.35 1.31 N.S.
Data are expressed as mean.
FHR, fetal heart rate; FM, fetal movements; ACC, accelerations; DEC,
deceleration; STV, short-term variability; ApEn, approximate entropy; NS,
not signiﬁcant.
∗Student’s t-test, ∗according to the standard values proposed by Arduini.
represented by a time series. It is a measurement of the
conditional probability that two vectors that are close to each
otherformpointswillremaincloseatthenextpoint[29,30].
Baseline FHR, accelerations, decelerations, long-term
irregularity (LTI), approximate entropy (ApEn), and fetal
movements (FMs) were calculated for deﬁned observational
periods before and after VAS (Figure 1).
The cCTG parameters short term variability (STV) and
the approximate entropy (ApEn) were analyzed in reference
to the standard values proposed by Arduini and associates,
for each gestational week [31, 32]. The aim of the study was
t oe v a l u a t et h ec h a n g e si nc C T Ga n a l y s i sb e f o r ea n da f t e r
an external vibratory acoustic stimulus over the fetal vertex,
by an artiﬁcial larynx, was produced. The stimulus consisted
of 5 seconds of vibration applied to the maternal abdomen,
while the fetus is sleeping, in accordance with the literature
and the clinical indications [33]. Data were also investigated
in relationship with the perinatal outcome. Adverse perinatal
outcome included one or more of the following criteria:
small for gestational age infant, fetal acidaemia at delivery,
5-minute Apgar score <7, respiratory distress syndrome,
perinatal death, hypoxic ischemic encephalopathy, malfor-
mations, or other injuries requiring neonatal intensive care.
Statistical analysis was performed using chi-square test
for independent samples, and the two-tailed Student’s t-test.
A P value < 0.05 was considered to be statistically signiﬁcant.
3. Results
Fetal vibroacoustic stimulation was performed on 121 high-
riskand95low-riskpregnancies,whiletheirFHRparameters
were monitored and recorded by cCTG analysis.
Signiﬁcant fetal heart accelerations (P<0.05) appeared
10 seconds after the stimulation both in low- and high-risk
pregnancies. As many authors argued [34, 35], this event can
be related to the sudden change of the fetal state from quiet
sleep to activity/weakeness.
In each group of patients, FHR after VAS remained
almost unmodiﬁed, as diﬀerences were not statistically sig-
niﬁcant (Tables 3 and 4). We considered positive a VAS test
if the stimulation is follwed by the increase of STV and the
decrease of ApEn. High-risk pregnant women showed an
Table 4: FHR parameters before and after VAS in high-risk
pregnancies (n = 121).
Before VAS After Vas P∗
FHR 136.12 136.33 N.S.
FM 31 75 0.001
N◦ ACC 2.1 9.7 0.001
DEC 0.02 0.13 N.S.
STV 4.41 5.92 0.005
ApEn 1.36 1.22 0.005
Data are expressed as mean.
FHR, fetal heart rate; FM, fetal movements; ACC, accelerations; DEC,
deceleration; STV, short-term variability; ApEn, approximate entropy; NS,
not signiﬁcant.
∗Student’s t-test.
increase of STV in 76 cases (62.8%), a decrease of ApEn
in 67 cases (55.37%), and a global positive test in 39 cases
(32.23%), including 31 (38.7%) with a favorable perinatal
outcome and 8 (20%) with an unfavorable outcome at birth.
In low-risk patients, we found an increase of STV in 72
cases (75.79%) and a decrease of ApEn in 49 cases (51.57%),
with a positive VAS test in 36 cases (37.90%), including
32 (37.20%) with a favorable perinatal outcome and 4
(44.4%) with an unfavorable outcome. 50 babies (23.4%)
showed adverse conditions at birth: 41 (33.88%) in high-risk
pregnancies and 9 (9.47%) in low-risk pregnant women.
FetalmovementssigniﬁcantlyincreasedafterVASinboth
the groups (P = 0.001). Only in the high-risk pregnancies,
the increase of STV and the decrease of ApEn after VAS were
signiﬁcantly associated with favorable perinatal outcomes.
Moreover, chi-square test (χ2) showed that only between
28th and 36th week of gestation and only when STV
increased more than 3.5ms and ApEn decreased more
than 0.5, the relationship with the perinatal outcome was
statistically signiﬁcant (Table 5). The radar graph in Figure 2
summarizes the cutoﬀ values found, oﬀering an immediate
visual evaluation about the diﬀerent relationships between
STV and ApEn with the perinatal outcome, respectively.
VAS predictive value was examined through the analysis
of sensitivity and speciﬁcity. Sensitivity was found to be 37%
in low-risk pregnancies, and 39% in high-risk pregnancies.
Instead, speciﬁcity was 55% and 80%, respectively, in low-
and high-risk pregnancies (Table 6).
4. Discussion
Vibroacoustic stimulation oﬀers a unique opportunity to
assess how the fetus responds to the external environment.
Fetal VAS is commonly used for both antepartum and in-
trapartum testing. It is considered a simple and reliable
prognostic evaluation of abnormal FHR detection. A meta-
analysis performed by Skupski et al. [36] of reports on
intrapartum fetal stimulation tests, analyzed diﬀerent types
of fetal stimulation, including scalp puncture for pH testing,
the use of an Allis clamp to pinch the fetal scalp, digital
stroking of the fetal scalp, and VAS. All the methods
resulted similar. Moreover, methods like fetal scalp blood4 Journal of Pregnancy
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Figure 1: Example of computerized analysis of fetal heart rate tracing.
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Figure 2: Radar graph representing the cutoﬀ values found for short term variability (STV) and approximate entropy (ApEn).Journal of Pregnancy 5
Table 5: Modiﬁcations of STV (a) and ApEn (b) after VAS in high-
risk pregnancies between 28th and 36th week of gestation.
(a) Ranges of increase of STV (ms) after VAS
Perinatal outcome 0–0.5 0.6–1 1.1–1.6 1.7–3.5 >3.5
Favorable (number) 2 2 2 1 3
Unfavorable (number) 8 2 3 5 0
(b) Ranges of decrease of ApEn after VAS
Perinatal outcome 0.2–0 0.5–0.3 >0.5
Favorable (number) 2 2 3
Unfavorable (number) 14 2 1
Table 6: Sensitivity and speciﬁcity analysis.
(a) High-risk pregnancies
Positive perinatal
outcome
Negative perinatal
outcome
Positive VAS Test 31 8
Negative VAS Test 49 33
Sensitivity = 31/(31 + 49) = 0,39 = 39%.
95% conﬁdence interval = 0,39 ± 1,96
√
0,39 · (1 − 0,39)/(31 + 49) =
0,2831–0,4969.
Speciﬁcity = 33/(8 + 33) = 0,8 = 80%.
95% conﬁdence interval = 0,8 ± 1,96
√
0,8 · (1 − 0,8)/(8 + 33)= 0,6776–
0,9224.
(b) Low-risk pregnancies
Positive perinatal
outcome
Negative perinatal
outcome
Positive VAS Test 32 4
Negative VAS Test 54 5
Sensitivity = 32/(32 + 54) = 0,37 = 37%.
95% conﬁdence interval = 0,37 ± 1,96
√
0,37 · (1 − 0,37)/(32 + 54) = 0,27–
0,47.
Speciﬁcity = 5/(4 + 5) = 0,55 = 55%.
95% conﬁdence interval = 0,55 ± 1,96
√
0,55 · (1− 0,55)/(4 + 5) = 0,23–
0,87.
sampling, fetal electrocardiography, and fetal pulse oximetry
are invasive, their beneﬁt can be uncertain, and are not
widely available or used routinely [37]. Fetal VAS is a
noninvasive technique that does not involve puncture of
the amniotic membrane, making it particularly useful in
antepartum primary care. Ohel et al. [8] demonstrated
that after vibroacoustic stimulation occurs, a statistically
signiﬁcant increase in basal FHR (115bpm) during periods
of low FHR reactivity and a statistically signiﬁcant increase
in the number of fetal movements happen. Bartnicki and
Dudenhausen [38] argued that after an acoustic stimulus,
fetal movements cause a partial occlusion of the umbilical
cord that could be responsible for the reduced fetal pressure
and acute hypoxia that would in turn lead to a reﬂex
stimulation of the autonomous nervous system.
From the current literature, we know that changes in
the beat-to-beat interval are mainly mediated by the reg-
ulation mechanisms and by the synergic action elicited by
the autonomic nervous system (ANS) activity, through its
sympathetic and parasympathetic branches. As the activities
of the ANS are closely related with those of the central ner-
vous system, and their contributions are usually quantiﬁed
through parameters obtained from the spectral analysis of
HRVsignal[39,40].Therefore,theanalysisofFHRsignalsof
fetusessubmittedtoavibroacousticstimulationmayprovide
information about the functional aspects of the autonomic
nervous system and of the central nervous system, making
possible diagnosis, prognosis, and monitoring of major
pathologies of the central or peripheral nervous system.
Cardiotocography (CTG) provides a noninvasive mon-
itoring of fetal heart rate (FHR). It is the most popular
analysis method in clinical practice allowing the recording
and the analysis of FHR, via ultrasonographic techniques.
Indices obtained from the cardiotocographic FHR signals
have been adopted to study the autonomic nervous system
activity of the fetus during the intrauterine life both in
physiologic and pathologic conditions [41]. Gonc ¸alvesetal.
[42] showed a signiﬁcant relationship between FHR linear
and nonlinear parameters and fetal state, as linear indices
increased signiﬁcantly with rising fetal activity whereas the
opposite occurred with nonlinear indices. D’Elia et al. [43]
used the computerized cardiotocography to assess the fetal
heart rate in healthy term fetuses subjected to VAS. He
found a statistically signiﬁcant increase not only for FM and
number of FHR accelerations, but also in STV. Moreover,
they showed that the response was inﬂuenced by fetus’
behavioural state at the time of the stimulus.
Interestingly, a study [44] performing a linear and
nonlinear fetal heart rate analysis in normal and acidemic
fetuses before delivery showed that, with the progression of
the labor, a signiﬁcant increase in linear frequency domain
indices and a signiﬁcant decrease in nonlinear indices
became evident. Bernardes et al. [45] hypothesized that fetal
sex diﬀerences could aﬀect the FHR response to VAS.
From our results, we can state that fetuses respond to
vibroacoustic stimulation accelerating their FHR. However,
the analysis of STV and ApEn after VAS shows that the
diﬀerence is signiﬁcant only in high-risk pregnancies. This
resultmakethesecCTGparametersausefultoolintheevalu-
ation of fetal neuronal response. Especially noteworthy is the
signiﬁcant association of a positive VAS test with perinatal
conditions in high-risk pregnancy, between the 28th and the
36th week of gestation. This result could be explained with
the development of the auditory apparatus, which occurs in
thatperiod.Indeed,vibroacousticstimulationelicitsaneural
responseinthefetus,fromtheauditorysensorysystemtothe
central level, whose response is able to trigger the autonomic
mechanisms responsible for the regulation of the FHR. The
identiﬁcation of cutoﬀ values of STV and ApEn for the
association with the perinatal outcomein high-risk pregnan-
cies could provide useful tools for better understanding and
management of pathophysiological neural development of
the fetus. In addition, the sensitivity and the speciﬁcity of the
resultsofthepresentstudywereanalyzed.Thelowsensitivity
values found, both in low- and high-risk pregnancies, show
that Vas test was positive only in a small number of patients
delivering healthy babies. On the other hand, the diﬀerence
between the two groups, found in the speciﬁcity analysis, is6 Journal of Pregnancy
very meaningful. The high percentage of speciﬁcity found
for high-risk pregnancies (80%) suggested that a negative
Vas test was observed in a large percentage of patients whose
babies show negative outcome at birth, in contrast with the
lower speciﬁcity (55%) found in low-risk pregnancies. This
is to conﬁrm the importance of the use of Vas test inside
the cCTG analysis as a predictive tool of conditions at birth.
Moreover, our ﬁndings can be seen as a conﬁrmation of
what Gonc ¸alves et al. [44] hypothesized, that is, an increase
in the autonomic nervous system activity and a decrease in
the central nervous system activity, when a stress condition
occurs (the ﬁnal minutes of labor in Gonc ¸alves’ study and
thevibroacousticstimulationinthepresentstudy),evenifwe
found diﬀerences between low- and high-risk pregnancies.
Diﬀerently from previous studies [4, 5, 8–10], our aim
was not to study only the role of Vas in relationship with
the modiﬁcations of fetal biophysical proﬁle, but we wanted
to analyze how its cardiotocographic eﬀect relates with the
perinatal outcome, in order to verify its predictive value.
Moreover, the present study tried to ﬁnd, for the ﬁrst time,
values of STV and ApEn from which it is possible to deﬁne
a statistical signiﬁcance of the relationship found. Further
randomized trials are surely needed to determine reliable
quantitative indices that could help a nearly recognition
of central and peripheral pathologies. For this purpose,
computerized cardiotocography analysis proves to be a
reliable noninvasive method.
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